Reference
Gazdic T, et al. Bortezomib-containing regimen for primary treatment of early antibody-mediated cardiac allograft rejection: a case report. Progress in Transplantation (Aliso Viejo, Calif.) 25: 147-52, No. 2, Jun 2015. Available from: URL: http://doi.org/10.7182/pit2015934 - Czech Republic
Rights and permissions
About this article
Cite this article
Bortezomib/methylprednisolone/rituximab/immune globulin. Reactions Weekly 1582, 96 (2015). https://doi.org/10.1007/s40278-015-12091-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-12091-2